<DOC>
	<DOCNO>NCT00209079</DOCNO>
	<brief_summary>The purpose trial test combination Gleevec® ( also know imatinib mesylate ) Taxotere ( also know docetaxel ) patient incurable stomach cancer . This study perform see combination Gleevec Taxotere effective treatment incurable stomach cancer minimal side effect .</brief_summary>
	<brief_title>Phase II Trial Gleevec Taxotere Combined Regimen Advanced Gastric Adenocarcinoma</brief_title>
	<detailed_description>The purpose trial test combination Gleevec® ( also know imatinib mesylate ) Taxotere ( also know docetaxel ) patient incurable stomach cancer . Gleevec pill form chemotherapy indicate treatment adult patient chronic myeloid leukemia ( CML ) gastrointestinal stromal tumor ( GIST ) . It consider experimental treatment stomach cancer . Taxotere ( docetaxel ) chemotherapy inject vein . It approve breast lung cancer show shrink many different type tumor . Taxotere show shrink stomach cancer 20 % - 30 % patient treat Taxotere . This study perform see combination Gleevec Taxotere effective treatment incurable stomach cancer minimal side effect . Treatment study consist two drug , Gleevec® Taxotere . Patients take four tablet Gleevec® daily throughout study . After one week Gleevec® , patient begin receive dos Taxotere intravenously week two week row follow one week without Taxotere .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>This study patient histologically confirm unresectable gastric adenocarcinoma receive chemotherapy 5FU adjuvant therapy either alone conjunction radiation . Patients may receive chemotherapy agent 5FU . Patients may receive 5FU therapy metastatic gastric cancer . Patients must 5 year free another primary malignancy except : primary malignancy basal cell skin cancer cervical carcinoma situ . Existence malignant disease allow . Patients must Grade III/IV cardiac problem , severe and/or uncontrolled medical disease ( i.e . uncontrolled diabetes , chronic renal disease , active uncontrolled infection ) . Patient must previously receive radiotherapy &gt; /= 25 % bone marrow , major surgery within 2 week prior study entry Final eligibility clinical trial determine health professional conduct trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Gastric Adenocarcinoma</keyword>
</DOC>